|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Recovery of previously written off receivables | |||||
| Depreciation expense | |||||
| Stock-based compensation | |||||
| Amortization of debt discount premium | |||||
| Impairment of fixed assets | |||||
| Amortization of right-of-use asset | |||||
| Loss on debt extinguishment | |||||
| Other current assets | |||||
| Increase (decrease) in liabilities: | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Accrued expenses – related parties | |||||
| Lease liability | |||||
| Net cash (used in) operating activities from continuing operations | |||||
| Net cash provided by operating activities from discontinued operations | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of fixed assets | |||||
| Proceeds from sale of subsidiary net assets | |||||
| Proceeds from sale of collateralized assets | |||||
| Net cash (used) in investing activities from continuing operations | |||||
| Net cash (used) in investing activities from discontinued operations | |||||
| Net cash (used) in investing activities | |||||
| Cash flows from financing activities | |||||
| Repayments of notes payable | |||||
| Proceeds from notes payable | |||||
| Repayments on convertible notes | |||||
| Proceeds from sale of preferred stock | |||||
| Proceeds from convertible notes | |||||
| Payments of deferred offering costs | |||||
| Repurchase of Series C Preferred stock | |||||
| Proceeds from sales of Series D Preferred shares | |||||
| Proceeds from sales of Series C Preferred shares | |||||
| Net cash provided by (used in) financing activities | |||||
| Net cash used in financing activities from discontinued operations | |||||
| Net increase (decrease) in cash | |||||
| Cash - beginning | |||||
| Cash - ending | |||||
| Supplemental disclosures: | |||||
| Interest paid | |||||
| Non-cash investing and financing activities: | |||||
| Addition of accounts payable and accrued interest into note payable | |||||
| Deferred offering costs accrued and unpaid | |||||
| Amortization of deferred offering costs | |||||
| Initial right-of-use asset valuation | |||||
| Common stock issued for settlement of stock payable | |||||
| Transfer of completed assets | |||||
| Warrants issued for debt financing | |||||
| Common stock issued for settlement of related party accrued compensation | |||||
| Common stock issued for conversion of note payable | |||||
Loading...